AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Centocor Inc. (joint venture with Corvas International Inc. to develop monoclonal antibody products) (Special Issue: Telecommunications in Belgium)

Business Memo from Belgium

| January 01, 1992 | COPYRIGHT 1992 Embassy of Belgium. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

CENTOCOR INC. announced an agreement with CORVAS INTERNATIONAL INC. to jointly develop and commercialize monoclonal antibody products. Corvas, based in San Diego and Ghent, Belgium, designs and develops ...

Related articles from newspapers, magazines, journals, and more
Corvas International Inc. (Business Notes) (Brief Article)
Magazine article from: San Diego Business Journal December 2, 1991 700+ words
Corvas International Inc. and Centocor...commercialize monoclonal antibody products. Under...license future monoclonal antibody products discovered...Corsevin M. is a monoclonal antibody-based drug designed...
Corvas International appoints new chairman and announces board changes.
Press release article from: Business Wire January 5, 1996 700+ words
...5, 1996--Corvas International Inc. (NNM...12D10Fab), a monoclonal antibody-based antithrombotic...said Woody. Corvas International Inc. is a biopharmaceutical...information on Corvas International Inc. via facsimile...
Dendreon Corporation and Corvas International Announce Form S-4 Registration...
Press release article from: Business Wire June 25, 2003 700+ words
...Nasdaq:DNDN) and Corvas International (Nasdaq:CVAS...Dendreon and Corvas International will now proceed...also includes monoclonal antibody and small molecule...About Corvas Corvas International, Inc. is a biopharmaceutical...
Dendreon Corporation Completes Acquisition of Corvas International; Creates...
Press release article from: Business Wire July 30, 2003 700+ words
...today announced that it has completed its acquisition of Corvas International (Nasdaq:CVAS). The acquisition provides Dendreon...cancers, Dendreon's product pipeline also includes monoclonal antibody, small molecule and prodrug product candidates. Dendreon...
Dendreon Corporation Stockholders Approve Acquisition of Corvas International.
Press release article from: Business Wire July 29, 2003 700+ words
...merger agreement pursuant to which Dendreon is acquiring Corvas International (Nasdaq:CVAS). Votes in favor of the merger were...cancers, Dendreon's product pipeline also includes monoclonal antibody and small molecule product candidates. Dendreon has...
Corvas International Appoints R. Douglas Norby to its Board of Directors
Press release article from: PR Newswire November 20, 1997 700+ words
...DIEGO, Nov. 20 /PRNewswire/ Corvas International, Inc. (Nasdaq: CVAS) announced...development through commercialization. Corvas International, Inc. is a biopharmaceutical company...455-9800. For information on Corvas International, Inc. via facsimile, call 1...
Synopsis of Corvas International, Inc. Presentation at Raymond James Eighteenth...
Press release article from: PR Newswire March 5, 1997 700+ words
...of the presentation made today by Corvas International, Inc. (Nasdaq: CVAS) at the...at the Don CeSar Beach Resort: Corvas International(Nasdaq: CVAS)is engaged in...site at www.corvas.com. SOURCE Corvas International, Inc. -0- 3/5/97 /CONTACT...
Corvas International announces R&D consolidation to lower company operating...
Press release article from: Business Wire December 2, 1994 700+ words
...BUSINESS WIRE)--Dec. 2, 1994--Corvas International Inc. (NNM:CVAS) Friday announced...research and development subsidiary, Corvas International, N.V., in Gent, Belgium...agreement has yet been reached. Corvas International, located in San Diego, is a biopharmaceutical...
Corvas International to Present at CIBC World Markets Health Care Conference.
Press release article from: PR Newswire October 29, 2002 700+ words
Corvas International, Inc. today announced that...days after the conference. Corvas International, Inc. is a biopharmaceutical...and Chief Executive Officer of Corvas International, Inc., +1-858-455...
Corvas International Reports Third Quarter 2002 Results.
Press release article from: PR Newswire October 22, 2002 700+ words
...PRNewswire-FirstCall/ -- FlashResults Corvas International, Inc. (In thousands, except...63) $(0.16) $(0.67) Corvas International, Inc. today reported financial...webcastsupport@tfprn.com.) About Corvas Corvas International, Inc. is a biopharmaceutical company...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA